Tumor Cell Viability in Clear Cell Sarcoma Requires DNA Binding Activity of the EWS/ATF1 Fusion Protein
Open Access
- 1 December 1999
- journal article
- Published by Elsevier
- Vol. 274 (49) , 34811-34818
- https://doi.org/10.1074/jbc.274.49.34811
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase IIOncogene, 1998
- The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directlyOncogene, 1998
- MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcriptionOncogene, 1998
- Anti-apoptotic Signaling by a Colony-stimulating Factor-1 Receptor/Insulin Receptor Chimera with a Juxtamembrane DeletionJournal of Biological Chemistry, 1998
- Apoptosis and necrosis in toxicology: A continuum or distinct modes of cell death?Pharmacology & Therapeutics, 1997
- The Emerging Molecular Genetics of Sarcoma TranslocationsDiagnostic Molecular Pathology, 1995
- The X-ray Structure of the GCN4-bZIP Bound to ATF/CREB Site DNA Shows the Complex Depends on DNA FlexibilityJournal of Molecular Biology, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Evaluation of glucocorticoid‐induced DNA fragmentation in mouse thymocytes by flow cytometryCell Proliferation, 1991
- Cytogenetic findings in clear cell sarcoma of tendons and aponeurosesCancer Genetics and Cytogenetics, 1991